4-HO-MET Facts
Psychedelic;
Description
4-HO-MET (4-hydroxy-N-methyl-N-ethyltryptamine) — metocin, methylcybin — is a synthetic psychedelic of the tryptamine class. It activates serotonin receptors in the brain, producing the visual distortions and altered thinking characteristic of classical psychedelics.[1]
Subjective effects include brightened colors, rippling surfaces, geometric visual patterns, synesthesia, mood elevation, and euphoria. The experience is lighter than psilocybin — visually rich and playful, with less introspective weight — though higher doses can produce ego dissolution and unusual thought patterns.[2]
4-HO-MET does not produce physical dependence,[3] and no human death has been attributed to the compound alone. The primary risks are psychological — panic, confusion, or acute psychosis[4] — and combining it with serotonin-raising drugs can trigger life-threatening overheating and seizures.[5]
Dose and durationby route · individual sensitivity varies
Starts in 15 – 30 minLasts 4 – 6 hoursAfter-effects 1 – 3 hours
Body and dependence
- Acute toxicity
- Low
- Chronic toxicity
- Low
- Physical dependence
- None
- Psychological dependence
- Negligible
- Withdrawal
- None recorded
- Compulsive redosing
- Negligible
Tolerance
- Builds
- Rapid
- Fully resets after
- 7 days
- Carries over to
- psilocybin;
psilocin; LSD; mescaline; DMT; 4-AcO-DMT; 4-HO-DET; 4-HO-DiPT
Effectslikely at a common dose
- Perception
- Geometry;
Color enhancement; Visual drifting; Color alteration; Environmental patterning; Music enhancement; Auditory enhancement; Visual breathing; +29 possible, including Spatial disorientation, Vestibular distortion, Visual haze / noise - Body
- Spontaneous body sensations;
Pupil dilation; Body high; Body scan awareness; +27 possible, including Heart rate perception changes, Temperature dysregulation, Muscle tension - Thinking
- Novelty enhancement;
Thought connectivity; Aesthetic enhancement; +26 possible, including Suggestibility enhancement, Cognitive impairment, Decision impairment - Feeling
- Emotional enhancement;
+6 possible, including Emotional lability, Anxiety - Self
- none likely · 10 possible, including Derealization, Depersonalization
- Time
- Time alteration;
+3 possible, including Temporal disorientation - Transpersonal
- none likely · 1 possible
- Awareness
- none likely · 5 possible
Who shouldn't take it
Combinations61 recorded
Seek help immediately if
Most difficulty is psychological (intense fear, panic, confusion) and passes with calm support — the signs below mean seek emergency help:
- Very high body temperature; hot, dry skin
- Seizures
- Chest pain; fast or irregular heartbeat
- Severe muscle rigidity, tremor, or twitching (possible serotonin syndrome)
- Cold, pale, or blue fingers/toes — severe vasoconstriction (notably NBOMe / DOx)
- Persistent vomiting; unconsciousness; uncontrollable agitation or risk of self-harm
What to do
- Stay calm and reassure — remind them they took a drug and the effect will pass
- Move to a calm, quiet, safe space with low light; reduce noise and sensory input
- Keep them from harm — they may act on fear or confusion; stay with them, don't leave them alone
- Talk them down gently; don't grab or restrain unless they're in danger
- For the medical signs above (overheating, seizure, chest pain, vasoconstriction, unresponsive) call emergency services
- If overheating, cool the body; be ready to give rescue breaths / CPR
The experience is time-limited and usually resolves with calm reassurance in a safe setting — psychological first aid, not medication. Serious physical harm is uncommon for classic psychedelics (LSD, psilocybin) but real for some potent phenethylamines (NBOMe, DOx), where hyperthermia, seizures, and vasoconstriction warrant emergency care.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]
- [2]^Kjellgren A, Soussan C (2011) Heaven and hell--a phenomenological study of recreational use of 4-HO-MET in Sweden — Journal of Psychoactive Drugs PMID:22111404
- [3]^de la Fuente Revenga M, Jaster AM, McGinn J, Silva G, Saha S, Gonzalez-Maeso J (2022) Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice — ACS Chemical Neuroscience doi:10.1021/acschemneuro.2c00170
- [4]^Täljemark J, Johansson BA (2012) Drug-induced acute psychosis in an adolescent first-time user of 4-HO-MET — European Child & Adolescent Psychiatry doi:10.1007/s00787-012-0282-9
- [5]^Rached G, Campana A, Fiani D, et al. (2026) Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances — CNS Drugs doi:10.1007/s40263-025-01256-7